Skip to main navigation Skip to search Skip to main content

Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI

Paul Sirajuddin, Sudeep Das, Lymor Ringer, Olga C. Rodriguez, Angiela Sivakumar, Yi Chien Lee, Aykut Üren, Stanley T. Fricke, Brian Rood, Alpay Ozcan, Sean S. Wang, Sana Karam, Venkata Yenugonda, Patricia Salinas, Emanuel Petricoin, Michael Pishvaian, Michael P. Lisanti, Yue Wang, Richard Schlegel, Bahram MoasserChris Albanese*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science